New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
InflaRx N.V. (IFRX)
IFRX · NGS · Common · CUSIP N44821101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IFRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
N44821101
IPO
11/7/2017 · 6.67 Million Shares @ $15.00/share
Prospectus
IPO prospectus »
Business: InflaRx N.V. is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.

Company Contact

CEO
Niels C. Riedemann
CFO
Thomas Taapken
Investor Relations
info@inflarx.de
SEC EDGAR Filings
View filings »